长链非编码RNA在糖尿病肾病中的研究进展
摘要
为复杂，涉及多种病理生理过程。越来越多的证据显示，不仅多种经典的信号通路参与DN足细胞损伤过程的调控，
而且表观遗传机制亦对足细胞损伤产生显著影响。近几年研究结果显示，长链非编码RNA（lncRNAs）在DN的发
病机制中发挥重要作用，lncRNAs广泛参与肾脏功能行使以及肾脏发育，在诊断方面显示出重要价值。
关键词
全文:
PDF参考
[1]Gheith O, Farouk N, Nampoory N, et al. Diabetic
kidney disease: world wide difference of prevalence and risk
factors[J]. J Nephropharmacol, 2016, 5(1):49-56.
[2]Global, regional, and national burden of chronic
kidney disease, 1990-2017: a systematic analysis for the
Global Burden of Disease Study 2017[J]. Lancet, 2020,
395(10225):709-733.
[3]Singh S, Sonkar S K, Sonkar G K, et al. Diabetic
kidney disease: A systematic review on the role of epigenetics
as diagnostic and prognostic marker[J]. Diabetes Metab Res
Rev, 2019, 35(5): e3155.
[4]Kato M, Natarajan R. Diabetic nephropathy--
emerging epigenetic mechanisms[J]. Nat Rev Nephrol, 2014,
10(9):517-530.
[5]Liu R, Lee K, He J C. Genetics and Epigenetics of
Diabetic Nephropathy[J]. Kidney Dis (Basel), 2015, 1(1):42-51.
[6]Kung J T, Colognori D, Lee J T. Long noncoding
RNAs: past, present, and future[J]. Genetics, 2013,
193(3):651-669.
[7]Kashi K, Henderson L, Bonetti A, et al. Discovery and
functional analysis of lncRNAs: Methodologies to investigate
an uncharacterized transcriptome[J]. Biochim Biophys Acta,
2016, 1859(1):3-15.
[8]St L G, Wahlestedt C, Kapranov P. The Landscape of
long noncoding RNA classification[J]. Trends Genet, 2015,
31(5):239-251.
[9]Kapranov P, Cheng J, Dike S, et al. RNA maps
reveal new RNA classes and a possible function for pervasive
transcription[J]. Science, 2007, 316(5830):1484-1488.
[10]Jayaram B, Syed I, Kyathanahalli C N, et al. Arf
nucleotide binding site opener [ARNO] promotes sequential
activation of Arf6, Cdc42 and Rac1 and insulin secretion in
INS 832/13 beta-cells and rat islets[J]. Biochem Pharmacol,
2011, 81(8):1016-1027.
[11]Lin J, Jiang Z, Liu C, et al. Emerging Roles of Long
Non-Coding RNAs in Renal Fibrosis[J]. Life (Basel), 2020,
10(8).
[12]Zoja C, Xinaris C, Macconi D. Diabetic
Nephropathy: Novel Molecular Mechanisms and Therapeutic
Targets[J]. Front Pharmacol, 2020, 11:586892.
[13]Hu M, Wang R, Li X, et al. LncRNA MALAT1
is dysregulated in diabetic nephropathy and involved in high
glucose-induced podocyte injury via its interplay with betacatenin[J]. J Cell Mol Med, 2017, 21(11):2732-2747.
[14]Li S Y, Susztak K. The long noncoding RNA
Tug1 connects metabolic changes with kidney disease in
podocytes[J]. J Clin Invest, 2016, 126(11):4072-4075.
[15]Hu C, Sun L, Xiao L, et al. Insights into theMechanisms Involved in the Expression and Regulation of
Extracellular Matrix Proteins in Diabetic Nephropathy[J].
Curr Med Chem, 2015, 22(24):2858-2870.
[16]Li Y, Xu K, Xu K, et al. Roles of Identified Long
Noncoding RNA in Diabetic Nephropathy[J]. J Diabetes
Res, 2019, 2019:5383010.
[17]Yi H, Peng R, Zhang L Y, et al. LincRNAGm4419 knockdown ameliorates NF-kappaB/NLRP3
inflammasome-mediated inflammation in diabetic
nephropathy[J]. Cell Death Dis, 2017, 8(2): e2583.
[18]Rask-Madsen C, King G L. Vascular complications
of diabetes: mechanisms of injury and protective factors[J].
Cell Metab, 2013, 17(1):20-33.
[19]Gong Q, Su G. Roles of miRNAs and long
noncoding RNAs in the progression of diabetic retinopathy[J].
Biosci Rep, 2017, 37(6).
[20]Tonolo G, Cherchi S. Tubulointerstitial disease in
diabetic nephropathy[J]. Int J Nephrol Renovasc Dis, 2014,
7:107-115.
[21]Raut S K, Khullar M. The Big Entity of New
RNA World: Long Non-Coding RNAs in Microvascular
Complications of Diabetes[J]. Front Endocrinol (Lausanne),
2018, 9:300.
[22]Feng M, Tang P M, Huang X R, et al. TGF-beta
Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long
Noncoding RNA Axis[J]. Mol Ther, 2018, 26(1):148-161.
Refbacks
- 当前没有refback。
